Chronic Pelvic Pain Treatment Market Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

The Global Chronic Pelvic Pain Treatment Market, valued at US$ 5.7 billion in 2021, is set to exhibit a steady CAGR of 3.6% from 2022 to 2031, reaching a projected valuation of more than US$ 8 billion by the end of 2031. Chronic pelvic pain, lasting six months or more, is attributed to factors such as surgery near the pelvic region, cancer, and pregnancy complications. The market has witnessed moderate growth in recent years, a trend expected to persist due to increased adoption of novel treatment procedures and government initiatives to spread awareness.

The global chronic pelvic pain treatment market is witnessing moderate growth, fueled by various factors. The demand for treatments and medications to alleviate pelvic pain is on the rise globally. Emerging treatment procedures such as acupuncture, chiropractic care, biofeedback therapy, and behavioral therapy are contributing to market growth. Additionally, health camps and government initiatives focused on raising awareness about pelvic pain treatments are playing a crucial role in augmenting the market.

Get Detailed Sample PDF: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84850

Overview of Chronic Pelvic Pain Treatment Market
Pelvic pain, affecting the pelvic bone or reproductive organs in both males and females, becomes chronic when persisting for six months or more. Chronic pelvic pain is often associated with behavioral, cognitive, and emotional consequences, along with symptoms of lower urinary tract, pelvic floor, or gynecological dysfunction. The market is witnessing the introduction of endoscopic devices for accurate diagnosis, offering significant opportunities for market players.

Rise in Awareness Driving Global Market
Chronic pelvic pain frequently coexists with non-pelvic pain disorders and comorbidities, leading to severe pain and disability. Lifestyle changes, consumption of hybrid foods, pollution, stress, anxiety, and depression contribute to diseases causing pelvic pain, particularly in women. Delay in receiving treatment can lead to unnecessary suffering, emphasizing the importance of awareness about causes and treatment options. This rise in awareness is expected to create growth opportunities for market players.

Access, Cost-effectiveness, and Medications Fuel Market Growth
The global chronic pelvic pain treatment market is categorized into medications, surgery, and others. The medication segment, encompassing pain relievers, hormone treatments, antibiotics, and antidepressants, dominated the market with a 70% share in 2021. The trend is expected to continue, driven by increased awareness about pain management medications. Over-the-counter pain relievers, including NSAIDs, paracetamol, codeine, ibuprofen, and aspirin, are widely consumed, further boosting the market.

Retail Pharmacies & Drug Stores Dominate Distribution Channels
In terms of distribution channels, retail pharmacies & drug stores accounted for a major share of around 65% in 2021. The growth is attributed to the preference for over-the-counter painkillers and medications available in pharmacies and drug stores. The trend of using generic drugs for chronic pelvic pain is on the rise, as nearly eight in 10 prescriptions filled in the U.S. are for generic drugs.

Regional Outlook
North America held the largest market share of around 36% in 2021, driven by the increasing incidence of chronic pelvic pain in the region. In the U.S., one in seven women suffers from chronic pelvic pain. Europe accounted for approximately 31% of the global market share in 2021, experiencing rapid growth due to heightened awareness and an increase in complete body check-ups. Asia Pacific surpassed Latin America and the Middle East & Africa in market share in 2021, with Latin America anticipated to grow at a faster CAGR during the forecast period.

Get Detailed Summary & TOC: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=84850

Analysis of Key Players in Chronic Pelvic Pain Treatment Market
The chronic pelvic pain treatment market report concludes with the company profiles section, which includes key information about the leading players in the global chronic pelvic pain treatment market. Leading players in the global chronic pelvic pain treatment market include Bayer AG, Becton, Dickinson and Company, GlaxoSmithKline plc, Hospiinz, Intuitive Surgical, MAST PAK SURGICAL CORP, Mayne Pharma Group Limited, Medtronic, and Perrigo Company plc.

Market Segmentation
Technology
• Medications
• Pain Relievers
• Hormone Treatments
• Antibiotics
• Antidepressants
• Surgery
• Laparoscopic Surgery
• Hysterectomy
• Others

Distribution Channel
• Retail Pharmacies & Drug stores
• E-commerce
• Others

Regions Covered
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Get Exclusive Discount on Chronic Pelvic Pain Treatment Market at: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=84850

About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.